The ₹500 Feluda test, a paper-based test strip to detect COVID-19 in less than 30 minutes, has been approved for commercial launch by DCGI. Feluda is the acronym for FNCAS9 Editor Linked Uniform Detection Assay. It uses indigenously developed CRISPR gene-editing technology to identify and target the genetic material of the virus that causes COVID-19.
The test has been developed by the Tata Group and CSIR-IGIB (Institute of Genomics and Integrative Biology). It is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID-19.